TcoF overview
| TcoF: | MED31 | |
| GeneID: | 23077 | |
| Name: | Mediator of RNA polymerase II transcription subunit 31 | |
| Ensembl: | ENSG00000108590 | |
| Species: | Human | |
| Class: | class 3 | |
| Family: | Mediator complex | |
| Disease: | 0 | |
| Go term: | 10 | |
| Pathway: | 3 | |
| Hallmark: | -- | |
| Super Enhancer: |
chr17:6543017-6561221 chr17:6540483-6561532 chr17:6542774-6558437 chr17:6539563-6561609 |
|
| Enhancer: |
chr17:6494100-6496590 chr17:6572370-6573370 chr17:6347810-6348390 chr17:6364880-6367050 chr17:6376150-6377750 chr17:6511780-6513310 chr17:6590990-6593400 chr17:6358960-6360910 chr17:6374680-6375970 chr17:6502640-6503690 chr17:6563830-6564520 chr17:6564700-6566630 chr17:6939900-6940040 chr17:7132590-7132690 chr17:7132770-7132900 chr17:7454290-7456610 chr17:6659430-6661400 chr17:6141360-6143730 chr17:6757380-6757530 chr17:6432930-6434410 chr17:6373730-6374480 chr17:6377920-6380340 chr17:6380530-6381290 chr17:6522800-6524100 chr17:6421900-6422650 chr17:6589660-6590840 chr17:6604450-6606280 chr17:6690280-6690610 chr17:6492000-6493090 chr17:6277220-6278860 chr17:6574280-6576300 chr17:6579000-6581460 chr17:6614240-6616550 chr17:6771770-6772300 chr17:6774690-6777100 chr17:6940190-6941470 chr17:6963260-6964840 chr17:7487280-7489050 chr17:6408620-6409390 chr17:6453630-6454410 chr17:6469790-6472260 chr17:6135210-6136140 chr17:6267920-6270280 chr17:6472490-6473780 chr17:6349820-6350400 chr17:6381420-6381860 chr17:6382060-6382780 chr17:6382800-6384080 chr17:6384140-6384730 chr17:6431700-6432250 chr17:6434600-6435210 chr17:6661540-6662120 chr17:6663920-6664010 chr17:6295870-6298280 |
|
| Promoter: |
chr17:6546631-6554954 |
ChIP-seq based regulatory details of MED31
| Sample ID | Experiment target | Biosample type | Biosample term name | GSM ID | Tissue type | Source |
|---|
Downstream target genes of MED31
Upstream regulatory details of MED31
Protein-protein interaction of MED31
| OFFICIAL_SYMBOL_A | OFFICIAL_SYMBOL_B | EXPERIMENTAL_SYSTEM | PUBMED_ID | ORGANISM_A_ID | ORGANISM_B_ID | SOURCE |
|---|---|---|---|---|---|---|
| MED31 | MED19 | Reconstituted Complex | 12584197 | 9606 | 9606 | BIOGRID |
| MED31 | ZSCAN1 | Two-hybrid | 20211142 | 9606 | 9606 | BIOGRID |
| MED31 | HTT | Reconstituted Complex | 15383276 | 9606 | 9606 | BIOGRID |
| MED31 | NAF1 | Two-hybrid | 32296183 | 9606 | 9606 | BIOGRID |
| MED31 | MED19 | Affinity Capture-MS | 24981860 | 9606 | 9606 | BIOGRID |
| MED31 | MED28 | Affinity Capture-MS | 24981860 | 9606 | 9606 | BIOGRID |
| MED31 | MED6 | Affinity Capture-MS | 24981860 | 9606 | 9606 | BIOGRID |
| MED31 | MED27 | Affinity Capture-MS | 24981860 | 9606 | 9606 | BIOGRID |
| MED31 | MED11 | Affinity Capture-MS | 24981860 | 9606 | 9606 | BIOGRID |
| MED31 | MED18 | Affinity Capture-MS | 24981860 | 9606 | 9606 | BIOGRID |
| MED31 | MED26 | Affinity Capture-MS | 24981860 | 9606 | 9606 | BIOGRID |
| MED31 | MED22 | Affinity Capture-MS | 24981860 | 9606 | 9606 | BIOGRID |
| MED31 | MED13L | Affinity Capture-MS | 24981860 | 9606 | 9606 | BIOGRID |
| MED31 | CDK19 | Affinity Capture-MS | 24981860 | 9606 | 9606 | BIOGRID |
| MED31 | CCNC | Affinity Capture-MS | 24981860 | 9606 | 9606 | BIOGRID |
| MED31 | CDK8 | Affinity Capture-MS | 24981860 | 9606 | 9606 | BIOGRID |
| MED31 | MED12L | Affinity Capture-MS | 24981860 | 9606 | 9606 | BIOGRID |
| MED31 | ACAD11 | Affinity Capture-MS | 24981860 | 9606 | 9606 | BIOGRID |
| MED31 | APOA2 | Affinity Capture-MS | 24981860 | 9606 | 9606 | BIOGRID |
| MED31 | RPAP2 | Affinity Capture-MS | 24981860 | 9606 | 9606 | BIOGRID |
Annotation of MED31
TCGA cancer survival map of MED31
Expression of MED31
Disease information of MED31